Vaginal microbiome composition

There are 5 papers on vaginal microbiome composition in aging research: 1 trial and 2 observational studies in people, 1 review. The newest story, Nov 19, 2026: “Treatment-induced menopause linked to lasting vaginal changes”.

Biomarker

5 papers study it4 findings

2 new papers in 30 daysSee all 5 papers on vaginal microbiome composition

“The overall vaginal microbiome composition was strongly tied to age, childbirth and menstrual cycle phase.”
A citizen-science-enabled catalogue of the vaginal microbiome and associated factorsNature microbiology2023doi:10.1038/s41564-023-01500-0
  • Human trial1
  • Humans2

Associations

4

Breast cancer therapy

mixedin humans1

1 study
  1. Breast cancer therapy is associated with vaginal microbiome composition in humans (Iatrogenic menopause; more pronounced changes in endocrine therapy recipients).

    HumansIatrogenic menopause; more pronounced changes in endocrine therapy recipientsvaginaUp to 33 monthsfemalesn = 60

    Treatment-induced menopause linked to lasting vaginal changes

    Research SquarePreprint

More on Breast cancer therapy

Menstrual cycle phase

mixedin humans1

1 study
  1. Menstrual cycle phase is associated with vaginal microbiome composition in humans.

    Humansvaginafemalesn = 3,345

Childbirth

mixedin humans1

1 study
  1. Childbirth is associated with vaginal microbiome composition in humans.

    Humansvaginafemalesn = 3,345

More on Childbirth

Age

mixedin humans1

1 study
  1. Age is associated with vaginal microbiome composition in humans.

    Humansvaginafemalesn = 3,345

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 23 papers in 12 months
Research Square

Treatment-induced menopause linked to lasting vaginal changes

Vaginal health worsened within three months of menopause onset in women receiving breast cancer therapy; bacterial shifts persisted for up to 33 months.Vaginal health worsened within three months of menopause onset in women receiving breast cancer therapy; bacterial shifts persisted for up to 33 months.

Preprint: cohort · 60 peopleGenitourinary syndrome of menopause